GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Kalbe Farma Tbk (OTCPK:PTKFY) » Definitions » Cyclically Adjusted FCF per Share

PTKFY (PT Kalbe Farma Tbk) Cyclically Adjusted FCF per Share : $0.49 (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is PT Kalbe Farma Tbk Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

PT Kalbe Farma Tbk's adjusted free cash flow per share for the three months ended in Sep. 2024 was $0.248. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.49 for the trailing ten years ended in Sep. 2024.

During the past 12 months, PT Kalbe Farma Tbk's average Cyclically Adjusted FCF Growth Rate was 16.20% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 7.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of PT Kalbe Farma Tbk was 8.60% per year. The lowest was 7.30% per year. And the median was 7.95% per year.

As of today (2024-11-10), PT Kalbe Farma Tbk's current stock price is $19.625. PT Kalbe Farma Tbk's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2024 was $0.49. PT Kalbe Farma Tbk's Cyclically Adjusted Price-to-FCF of today is 40.05.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of PT Kalbe Farma Tbk was 79.97. The lowest was 38.90. And the median was 56.92.


PT Kalbe Farma Tbk Cyclically Adjusted FCF per Share Historical Data

The historical data trend for PT Kalbe Farma Tbk's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kalbe Farma Tbk Cyclically Adjusted FCF per Share Chart

PT Kalbe Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.32 0.41 0.40 0.36 0.62

PT Kalbe Farma Tbk Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.53 0.62 0.71 0.41 0.49

Competitive Comparison of PT Kalbe Farma Tbk's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - General subindustry, PT Kalbe Farma Tbk's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kalbe Farma Tbk's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Kalbe Farma Tbk's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where PT Kalbe Farma Tbk's Cyclically Adjusted Price-to-FCF falls into.



PT Kalbe Farma Tbk Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PT Kalbe Farma Tbk's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.248/130.3609*130.3609
=0.248

Current CPI (Sep. 2024) = 130.3609.

PT Kalbe Farma Tbk Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 0.170 98.819 0.224
201503 0.098 98.388 0.130
201506 0.035 99.766 0.046
201509 0.136 101.037 0.175
201512 0.192 102.133 0.245
201603 0.009 102.764 0.011
201606 0.055 103.212 0.069
201609 0.177 104.142 0.222
201612 0.103 105.222 0.128
201703 0.043 106.476 0.053
201706 0.051 107.722 0.062
201709 0.089 108.020 0.107
201712 0.062 109.017 0.074
201803 0.063 110.097 0.075
201806 0.010 111.085 0.012
201809 0.180 111.135 0.211
201812 0.156 112.430 0.181
201903 -0.036 112.829 -0.042
201906 0.018 114.730 0.020
201909 0.054 114.905 0.061
201912 0.123 115.486 0.139
202003 0.091 116.252 0.102
202006 0.158 116.630 0.177
202009 0.219 116.397 0.245
202012 0.441 117.318 0.490
202103 0.004 117.840 0.004
202106 0.033 118.184 0.036
202109 0.406 118.262 0.448
202112 0.101 119.516 0.110
202203 0.053 120.948 0.057
202206 -0.057 123.322 -0.060
202209 -0.007 125.298 -0.007
202212 0.121 126.098 0.125
202303 0.002 126.953 0.002
202306 0.014 127.663 0.014
202309 0.182 128.151 0.185
202312 0.285 129.395 0.287
202403 0.240 130.607 0.240
202406 0.225 130.792 0.224
202409 0.248 130.361 0.248

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


PT Kalbe Farma Tbk  (OTCPK:PTKFY) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

PT Kalbe Farma Tbk's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=19.625/0.49
=40.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of PT Kalbe Farma Tbk was 79.97. The lowest was 38.90. And the median was 56.92.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


PT Kalbe Farma Tbk Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of PT Kalbe Farma Tbk's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kalbe Farma Tbk Business Description

Traded in Other Exchanges
Address
Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, Jakarta, IDN, 10510
PT Kalbe Farma Tbk is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

PT Kalbe Farma Tbk Headlines

No Headlines